Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The objective of this study was to investigate the bioequivalence of Mylan\'s ondansetron orally disintegrating 8 mg tablets to GlaxoSmithKline\'s Zofran ODT® 8 mg tablets following a single, oral 8 mg (1 x 8 mg) dose administered under fed conditions.
Epistemonikos ID: 3486f3ed2365d4ca66a816a364216826c6ead994
First added on: May 04, 2024